Gm53261 Gene Detail

Summary

• Symbol
  Gm53261
• Name
  predicted gene, 53261

• Feature Type
  protein coding gene
  BioType Conflict
  
• IDs
  MGI:6721595
  NCBI Gene: 118567343
• Alliance
  gene page

Location &
Maps

• Sequence Map
  Chr17:6683457-6694383 bp, - strand

  From Ensembl annotation of GRCm39
  

• View this region in JBrowse
  

• Genome Browsers
  Ensembl | UCSC | NCBI

• Genetic Map
  Chromosome 17, Syntenic
• Mapping Data
  1 experiment

Strain
Comparison

• SNPs within 2kb
  98 from dbSNP Build 142
• Strain Annotations
  1

Strain	Gene Model ID	Feature Type	Coordinates
C57BL/6J	MGI_C57BL6J_6721595	protein coding gene	Chr17:6637343-6695185 (-)
129S1/SvImJ	no annotation
A/J	no annotation
AKR/J	no annotation
BALB/cJ	no annotation
C3H/HeJ	no annotation
C57BL/6NJ	no annotation
CAROLI/EiJ	no annotation
CAST/EiJ	no annotation
CBA/J	no annotation
DBA/2J	no annotation
FVB/NJ	no annotation
LP/J	no annotation
NOD/ShiLtJ	no annotation
NZO/HlLtJ	no annotation
PWK/PhJ	no annotation
SPRET/EiJ	no annotation
WSB/EiJ	no annotation

Homology

• Gene Tree
  Gm53261
  

Human Diseases

• References
  6 with disease annotations

Mutations,
Alleles, and
Phenotypes

• Phenotype Summary
  348 phenotype references
  

• All Mutations and Alleles
  1
• Radiation induced
  1
• Genomic Mutations
  1 involving Gm53261
• Find Mice (IMSR)
  0 strains or lines available

Sequences &
Gene Models

• All Sequences
  11
• RefSeq
  7

• Ensembl
  ENSMUSG00000122706 (Evidence)
• NCBI Gene
  118567343

Representative Sequences			Length	Strain/Species
genomic	ENSMUSG00000122706	Ensembl Gene Model | MGI Sequence Detail	10927	C57BL/6J
transcript	ENSMUST00000254442	Ensembl | MGI Sequence Detail	1313	Not Applicable
polypeptide	XP_036016758	RefSeq | MGI Sequence Detail	305	C57BL/6J

References

• Summaries
  All 351

  Diseases 6

  Phenotypes 348
• Earliest
  J:30229 Davisson MT, et al., Segmental trisomy as a mouse model for Down syndrome. Prog Clin Biol Res. 1993;384:117-33
• Latest
  J:354984 Emili M, et al., Reversal of neurodevelopmental impairment and cognitive enhancement by pharmacological intervention with the polyphenol polydatin in a Down syndrome model. Neuropharmacology. 2024 Sep 27;261:110170